HAI Book 2025 - Flipbook - Page 50
From the clinical utility of a-synuclein PET
imaging in Multiple System Atrophy to the
possible diagnosis of Parkinson9s disease
Unraveling the impact of amyloid-´ and tau
pathology on brain structure and cognitive
function during preclinical and prodromal
Alzheimer9s disease
Astrogliosis, a potential non-A´ pathway to tau
APOE ε4 carriers exhibit attenuated habituation
in pupil size and practice effects on a repeated
auditory oddball task
Baseline tau burden and performance on a digital
clock drawing test uniquely contributes to
predicting future tau accumulation in preclinical
AD
Francesca Capotosti, AC Immune SA, EPFL
Innovation Park, Building B, Lausanne, CH
Ting Qiu, Douglas Mental Health University
Institute, McGill University, Montreal, QC, CA
Victor L Villemagne, Department of
Psychiatry, University of Pittsburgh,
Pittsburgh, PA, US
Victor L Villemagne, Department of
Psychiatry, University of Pittsburgh,
Pittsburgh, PA, US
Jessie Fang-Lu Fu, Athinoula A. Martinos
Center for Biomedical Imaging, Boston, MA, US
Molecular correlates of apraxia in Alzheimer's
disease: A PET imaging study
Gerard Bischof, University of Cologne,
University Hospital of Cologne, Department of
Nuclear Medicine, Multimodal Neuroimaging
Group, Cologne, Germany, Cologne, DE
Understanding the impact of race on white
matter hyperintensities in Alzheimer9s disease:
Findings from the ADNI Study
Victor Ekuta, Morehouse School of Medicine,
Atlanta, GA, US
Characterization of a limbic-predominant
amnestic neurodegenerative syndrome
Positron emission tomography analysis with the
dynamicpet Python package
Targeted plasma eQTL and pQTL to identify
potential novel biomarker for Alzheimer's
Disease in African Americans
Pathological and clinical trajectories of
preclinical Alzheimer9s disease patients with
divergent cortical tau patterns
Evaluation of a label-free X-ray based method
for estimating amyloid load in the human brain
Proteomic analyses of A-T-N reveal plasma
mediators of neurodegeneration and dementia
risk
The spatial spread of tauopathy precedes the
increase in tau-PET load in Alzheimer9s disease
Distinct patterns of Iron distribution in the
entorhinal cortex-hippocampus system for
characterization of mild cognitive impairment
Pathological asymmetry in early onset AD
reflects heterogenous disease trajectories
Characterizing amyloid-positive with low Tau
(A+T-) profiles and their association with
cognitive trajectories in the Longitudinal EarlyHAI2025 - 50
Nick Corriveau-Lecavalier, Department of
Psychiatry and Psychology, Mayo Clinic,
Rochester, MN, US
Murat Bilgel, Laboratory of Behavioral
Neuroscience, National Institute on Aging,
Baltimore, MD, US
Murat Bilgel, Laboratory of Behavioral
Neuroscience, National Institute on Aging,
Baltimore, MD, US
Elizabeth Mormino, Department of Neurology
and Neurological Sciences, Stanford
University School of Medicine, Stanford, CA,
US
Danielle Geremia, Division of Imaging,
Diagnostics, and Software Reliability, Office of
Science and Engineering Laboratories, Center
for Devices and Radiological Health, Food and
Drug Administration, Silver Spring, MD, US
Michael Duggan, Laboratory of Behavioral
Neuroscience, National Institute on Aging,
National Institutes of Health, Baltimore, MD,
US
Arthur Cassa Macedo, Department of
Neurology and Neurosurgery, McGill University,
Montreal, QC, CA
Paul Unschuld, Institute for Regenerative
Medicine (IREM), University of Zurich, Zurich,
CH
Jacob Ziontz, Memory and Aging Center,
Department of Neurology, University of
California San Francisco, San Francisco, CA,
US
Maison Abu Raya, Memory and Aging Center,
Department of Neurology, Weill Institute for
Neurosciences, University of California, San
